On the one hand, resveratrol, at low doses, has been demonstrated to inhibit lung metastasis in breast cancer by decreasing the generation and function of tumor-evoked regulatory B cells (tBreg) via the inhibition of the STAT3 pathway. This evidence concerns the gene STAT3 and neoplasm.